Daiwa Securities Group Inc. Trims Stock Position in Revvity Inc. $RVTY

Daiwa Securities Group Inc. cut its holdings in shares of Revvity Inc. (NYSE:RVTY) by 25.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,397 shares of the company’s stock after selling 8,929 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Revvity were worth $2,554,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in RVTY. AQR Capital Management LLC raised its holdings in shares of Revvity by 5.2% in the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after purchasing an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Revvity by 6.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC raised its holdings in shares of Revvity by 102.0% in the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Revvity by 45.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after purchasing an additional 189,871 shares during the period. Finally, Focus Partners Wealth raised its holdings in shares of Revvity by 13.0% in the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after purchasing an additional 811 shares during the period. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Price Performance

RVTY stock opened at $104.09 on Wednesday. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The stock has a 50-day simple moving average of $94.07 and a 200-day simple moving average of $97.67. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The firm has a market cap of $11.61 billion, a P/E ratio of 49.81, a price-to-earnings-growth ratio of 2.19 and a beta of 1.11.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same quarter last year, the firm earned $1.01 EPS. Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, equities analysts predict that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is 13.40%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on RVTY shares. JPMorgan Chase & Co. cut their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Barclays raised their price objective on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Wolfe Research started coverage on Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. The Goldman Sachs Group cut their price objective on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a report on Tuesday, April 14th. Finally, Robert W. Baird set a $117.00 price objective on Revvity in a report on Wednesday, May 6th. Four research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Revvity currently has a consensus rating of “Hold” and an average price target of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.